Nova Mentis Life Science Corp. (CSE: NOVA)
Canada
· Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
Sep 26, 2024, 4:00 PM EDT
Nova Mentis Life Science Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
741.59K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Green Thumb Industries Inc. | 1.52B |
Trulieve Cannabis Corp. | 1.59B |
Cresco Labs Inc. | 1.01B |
Planet 13 Holdings Inc. | 139.22M |
Ayr Wellness Inc. | 635.84M |
Grown Rogue International Inc. | 28.83M |
Jushi Holdings Inc. | 360.23M |
iAnthus Capital Holdings, Inc. | 229.29M |
Nova Mentis Life Science News
- 4 weeks ago - Nova Mentis Assigns Intellectual Property - Newsfile Corp
- 7 weeks ago - CSE Bulletin: WITHDRAWN - Symbol Change - Inactive Designation - Nova Mentis Life Science Corp. (NOVA) - Newsfile Corp
- 7 weeks ago - CSE Bulletin: Symbol Change - Inactive Designation - Nova Mentis Life Science Corp. (NOVA) - Newsfile Corp
- 7 months ago - Nova Mentis Announces Change of Directors - Newsfile Corp
- 11 months ago - Nova Mentis Applauds Government Decision to Create Rare Disease Advisory Group - Newsfile Corp
- 1 year ago - Nova Mentis Announces Participant Screening Underway in Canada's First Psilocybin Clinical Trial for Fragile X Syndrome - Newsfile Corp
- 1 year ago - Nova Mentis to Enter mRNA AI Diagnostics Business - Newsfile Corp
- 1 year ago - Nova Mentis Begins Recruitment in First-of-its-Kind Health Canada Psilocybin Trial - Newsfile Corp